- Home
- CTNM vs RMAX Comparison
CTNM vs RMAX Comparison
Compare CTNM & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- RMAX
- Stock Information
- Founded
- CTNM 2009
- RMAX 1973
- Country
- CTNM United States
- RMAX United States
- Employees
- CTNM N/A
- RMAX N/A
- Industry
- CTNM
- RMAX Real Estate
- Sector
- CTNM
- RMAX Finance
- Exchange
- CTNM Nasdaq
- RMAX Nasdaq
- Market Cap
- CTNM 199.3M
- RMAX 191.6M
- IPO Year
- CTNM 2024
- RMAX 2013
- Fundamental
- Price
- CTNM $7.59
- RMAX $9.11
- Analyst Decision
- CTNM Strong Buy
- RMAX Hold
- Analyst Count
- CTNM 4
- RMAX 4
- Target Price
- CTNM $29.25
- RMAX $9.17
- AVG Volume (30 Days)
- CTNM 56.2K
- RMAX 109.8K
- Earning Date
- CTNM 03-04-2025
- RMAX 02-20-2025
- Dividend Yield
- CTNM N/A
- RMAX N/A
- EPS Growth
- CTNM N/A
- RMAX N/A
- EPS
- CTNM N/A
- RMAX 0.37
- Revenue
- CTNM N/A
- RMAX $307,685,000.00
- Revenue This Year
- CTNM N/A
- RMAX N/A
- Revenue Next Year
- CTNM N/A
- RMAX $0.68
- P/E Ratio
- CTNM N/A
- RMAX $24.62
- Revenue Growth
- CTNM N/A
- RMAX N/A
- 52 Week Low
- CTNM $7.04
- RMAX $6.94
- 52 Week High
- CTNM $22.00
- RMAX $14.31
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- RMAX 33.85
- Support Level
- CTNM N/A
- RMAX $9.98
- Resistance Level
- CTNM N/A
- RMAX $10.61
- Average True Range (ATR)
- CTNM 0.00
- RMAX 0.40
- MACD
- CTNM 0.00
- RMAX -0.01
- Stochastic Oscillator
- CTNM 0.00
- RMAX 20.41
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.